James Olson
Pediatric Hematology-Oncology · Seattle, WANPI 1518048875
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $704 of the $704 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Pfizer.
Across 1 payment — averaging $703.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$704
Across 2 payments — averaging $449,263 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Seagen Inc.$899K
What the payments were for
- Travel & lodging$704100%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 1 | $704 |
How this compares
$704 in reported general payments places this provider in the 55th percentile of 60 pediatric hematology-oncology providers in Washington.
See all pediatric hematology-oncology providers in Washington →
Other pediatric hematology-oncology in Seattle
- Allison WheelerSeattle$318K
- Rachel RauSeattle$87K
- Paul CarpenterSeattle$40K
- Kasey LegerSeattle$19K
- Douglas HawkinsSeattle$13K
- Rebecca GardnerSeattle$11K
- Michael BenderSeattle$9K
- Navin PintoSeattle$8K
- Whitney EngSeattle$8K
- Kristin MaherSeattle$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.